EP1984351 - COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.01.2013 Database last updated on 13.11.2024 | Most recent event Tooltip | 25.01.2013 | Application deemed to be withdrawn | published on 27.02.2013 [2013/09] | Applicant(s) | For all designated states Memory Pharmaceuticals Corporation 100 Philips Parkway Montvale, NJ 07645 / US | [2008/44] | Inventor(s) | 01 /
DUNN, Robert 3 Osborne Place Towaco, NJ 07082 / US | 02 /
NGUYEN, Truc, Minh 1732 46th.Street Des Moines, 50310 Iowa / US | 03 /
XIE, Wenge 2347 Pembroke Court Mahwah, NJ 07430 / US | 04 /
TEHIM, Ashok 246 N Walnut St Ridgewood, NJ 07450 / US | [2008/51] |
Former [2008/44] | 01 /
DUNN, Robert 3 Osborne Place Towaco, NJ 07082 / US | ||
02 /
NGUYEN, Truc, Minh 3 East 101 St Apt 5e New York, NY 10029 / US | |||
03 /
XIE, Wenge 2347 Pembroke Court Mahwah, NJ 07430 / US | |||
04 /
TEHIM, Ashok 246 N Walnut St Ridgewood, NJ 07450 / US | Representative(s) | Pistolesi, Roberto, et al Dragotti & Associati Srl Via Nino Bixio, 7 20129 Milano / IT | [N/P] |
Former [2008/44] | Pistolesi, Roberto, et al Dragotti & Associati srl Via Marina 6 20121 Milano / IT | Application number, filing date | 07757140.4 | 16.02.2007 | [2008/44] | WO2007US62340 | Priority number, date | US20060774399P | 17.02.2006 Original published format: US 774399 P | [2008/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007098418 | Date: | 30.08.2007 | Language: | EN | [2007/35] | Type: | A1 Application with search report | No.: | EP1984351 | Date: | 29.10.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.08.2007 takes the place of the publication of the European patent application. | [2008/44] | Search report(s) | International search report - published on: | EP | 30.08.2007 | Classification | IPC: | C07D401/04, C07D471/04, C07D417/14, C07D405/14, C07D403/14, A61K31/404, A61P25/00 | [2008/44] | CPC: |
C07D401/04 (EP,US);
A61P1/04 (EP);
A61P1/10 (EP);
A61P1/14 (EP);
A61P25/00 (EP);
A61P25/06 (EP);
A61P25/08 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/32 (EP);
A61P25/34 (EP);
A61P25/36 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P31/12 (EP);
A61P37/04 (EP);
A61P37/08 (EP);
A61P39/02 (EP);
A61P43/00 (EP);
A61P7/04 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07D403/14 (EP,US);
C07D405/14 (EP,US);
C07D417/14 (EP,US);
C07D471/04 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/44] | Extension states | AL | 26.03.2008 | BA | 26.03.2008 | HR | 26.03.2008 | MK | 26.03.2008 | RS | 26.03.2008 | Title | German: | VERBINDUNGEN MIT 5-HT6-REZEPTOR-AFFINITÄT | [2008/44] | English: | COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | [2008/44] | French: | COMPOSES AYANT UNE AFFINITE POUR LE RECEPTEUR 5-HT6 | [2008/44] | Entry into regional phase | 26.03.2008 | National basic fee paid | 26.03.2008 | Designation fee(s) paid | 26.03.2008 | Examination fee paid | Examination procedure | 26.03.2008 | Amendment by applicant (claims and/or description) | 26.03.2008 | Examination requested [2008/44] | 25.05.2012 | Despatch of a communication from the examining division (Time limit: M04) | 01.09.2012 | Application deemed to be withdrawn, date of legal effect [2013/09] | 10.10.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2013/09] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.05.2012 | Fees paid | Renewal fee | 09.02.2009 | Renewal fee patent year 03 | 08.02.2010 | Renewal fee patent year 04 | 06.01.2011 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 29.02.2012 | 06   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9213856 (PFIZER [US]) [X] 1-62 * example - *; | [Y]WO0063203 (ALLELIX BIOPHARMA [CA]) [Y] 1-62 * the whole document *; | [Y]WO0112629 (NPS ALLELIX CORP [CA]) [Y] 1-62 * the whole document *; | [Y]WO02051837 (WYETH CORP [US]) [Y] 1-62 * the whole document *; | [YD]US6133287 (SLASSI ABDELMALIK [CA], et al) [YD] 1-62 * the whole document *; | [YD]US6686374 (EDWARDS LOUISE [CA], et al) [YD] 1-62 * the whole document * | [X] - COLE D C ET AL, "N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (20050117), vol. 15, no. 2, ISSN 0960-894X, pages 379 - 383, XP004694276 [X] 1-62 * examples 15l,15y,15z * DOI: http://dx.doi.org/10.1016/j.bmcl.2004.10.064 |